Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Type 1 Diabetes
Interventions
DEVICE

FlorenceD or similar closed loop glucose control system

Subject's glucose level will be controlled by the FlorenceD or similar automated closed loop glucose control system. The system comprises of FreeStyle Navigator® Continuous Glucose Monitoring (CGM) System (Abbott Diabetes Care, Alameda, CA, USA), Dana R Diabecare subcutaneous insulin infusion pump (Sooil Corp. Seoul, South Korea)or similar insulin pump, and MPC-based glucose control algorithm running on a portable computer.

DEVICE

CSII with real-time CGM

Subject glucose level controlled by usual insulin pump therapy in conjunction with real time continuous glucose monitoring (CGM)

Trial Locations (3)

A- 8036

Medical University of Graz, Graz

D-41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

collaborator

Medical University of Graz

OTHER

lead

University of Cambridge

OTHER

NCT01666028 - Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes | Biotech Hunter | Biotech Hunter